P-79 C-PRECISE-01 study: A phase Ib/II trial of MEN1611, a...

Annals of Oncology 2020 / 07 Vol. 31

P-79 C-PRECISE-01 study: A phase Ib/II trial of MEN1611, a PI3K inhibitor, and cetuximab in patients with PIK3CA mutated metastatic colorectal cancer failing irinotecan, oxaliplatin, 5-FU and anti-EGFR containing regimens

Tabernero, J., Fernandez, E. Elez, Ghiringhelli, F., Folprecht, G., Curigliano, G., Siena, S., Cremolini, C., Sobrero, A., Kwiatek, M., Keränen, S. Roselló, Ahn, D., Punt, C., Laurent, D., Ferrara,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.04.161
Date:
July, 2020
File:
PDF, 93 KB
2020
Conversion to is in progress
Conversion to is failed